BioStem Technologies, Inc. BSEM
1.13 USD +0.09 (+8.65%)
At closeNov 6, 2026, 4:09 PM EST
1.12 -0.01 -0.88%
After hours · Nov 6, 4:09 PM ET
1.01 Day range 1.15
1.04 52-week range 8.20
- YTD
- -70.34%
- 1 year
- -70.80%
News
benzinga.com Why Cloudflare Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket Cloudflare jumped 14.6% after beating Q3 estimates; JFrog and Eton gained, while Site Centers and Biostem plunged premarket.
benzinga.com BioStem Secures US Patent, Additional US And Mexico Allowances For Tissue Technologies BioStem Technologies, Inc. (NASDAQ:BSEM) ("BioStem" or the "Company"), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue
benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session Gainers IM Cannabis (NASDAQ:IMCC) stock increased by 246.0% to $6.02 during Friday's regular session. The market value of their outstanding shares is at $1.0 million. SkyAI (NASDAQ:SKYA) stock rose…
benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session Gainers Liminatus Pharma (NASDAQ:LIMN) stock increased by 48.4% to $0.16 during Thursday's regular session. The market value of their outstanding shares is at $7.2 million. BeyondSpring (NASDAQ:BYSI)…
benzinga.com BioStem Technologies Q2 EPS $(0.52), Sales $7.899M Down From $10.963M YoY BioStem Technologies (NASDAQ:BSEM) reported quarterly losses of $(0.52) per share. The company reported $7.899 million in sales this quarter. This is a 27.95 percent decrease over sales of $10.963…
benzinga.com BioStem Technologies Announces It Received Nasdaq Approval For The Company’s Common Stock For Listing On The Nasdaq Capital Market; Co. To Begin Trading On Nasdaq On August 7, 2026 Under The Ticker Symbol "BSEM" BioStem Technologies Inc. (OTC:BSEM) ("BioStem" or the "Company"), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue…
benzinga.com Biostem Technologies Files Form 10 Share Registration Statement With The SEC; Reaffirms Planned Nasdaq Listing "The filing of our Registration Statement is an important milestone that advances our path toward a Nasdaq uplisting and reflects our significant commitment to operating as an SEC reporting company,"…- benzinga.com NovaBay Pharmaceuticals Announces Agreement with BioStem Technologies to Commercialize Amniotic Tissue Allograft as Avenova Allograft NovaBay Pharmaceuticals, Inc. (NYSE:NBY) and BioStem Technologies, Inc. (OTC:BSEM) announce an agreement under which NovaBay has been granted the right to commercialize BioStem Technologies' Amniotic…
- benzinga.com EXCLUSIVE: BioStem Technologies Reports Q1 Net Revenue Up 211% YoY BioStem Technologies Inc. (OTC: BSEM), a regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics today, reported financial results…